Table 4.

Interferon-γ results in mIU/ml in the different study groups.

Study group	n	Mean	SD*	Median	Min	Max
No COVID-19	52	20	38	2	0	193
Past infection >6mo	90	885	1584	356	17	12,149
Past infection <6mo	16	1206	1224	838	151	5383
BNT162b2 1. dose	38	2445	5522	1008	7	34,300
BNT162b2 2. dose	38	14,269	18,437	5198	245	67,049
AZD1222 1. dose	30	9847	17,207	1421	64	67,748
AZD1222/mRNA1273	27	6492	16,969	4440	245	67,049
Immunocompromised patients, IgG positive	54	1475	2852	501	0	13,250
Immunocompromised patients, IgG negative	76	583	1553	59	0	11,700

^⁎SD Standard deviation.